Safety Data Timelines for Pregnant Individuals With HIV on Antiretroviral Therapy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 38709816.
- Also identified by DOI 10.1093/cid/ciae249.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiretrovirals are often approved by the Food and Drug Administration without sufficient safety data regarding their use in pregnancy. To quantify this delay, we calculated the interval from the approval date to their inclusion in the Antiretroviral Pregnancy Registry prospective analysis (≥200 first-trimester exposures); the median delay was 6 years.
Medical subject headings
- HIV Infections
- Pregnancy Complications, Infectious
- Anti-HIV Agents